SPX3,801.28+10.35 0.27%
DIA304.07+0.93 0.31%
IXIC11,193.72+17.32 0.16%

BRIEF-Heart Test Laboratories Inc Says On Track For MyoVista FDA De Novo Resubmission In Current Fiscal Year

BRIEF-Heart Test Laboratories Inc Says On Track For MyoVista FDA De Novo Resubmission In Current Fiscal Year

Reuters · 09/13/2022 09:20
BRIEF-Heart Test Laboratories Inc Says On Track For MyoVista FDA De Novo Resubmission In Current Fiscal Year

- Heart Test Laboratories Inc HSCS.O:

  • HEART TEST LABORATORIES INC - REMAINS ON TRACK FOR MYOVISTA® FDA DE NOVO RESUBMISSION IN CURRENT FISCAL YEAR

  • HEART TEST LABORATORIES INC - NEARING COMPLETION OF PATIENT RECRUITMENT IN FDA PIVOTAL CLINICAL VALIDATION STUDY OF MYOVISTA®

  • HEART TEST-CONTINUES TO CAREFULLY MANAGE EXPENSES & BELIEVES HAS SUFFICIENT CAPITAL TO SUPPORT OPERATIONS BEYOND RESUBMISSION FOR FDA DE NOVO CLEARANCE

Source text for Eikon: ID:

Further company coverage: HSCS.O


((Reuters.Briefs@thomsonreuters.com;))